19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)

26S proteasome non-ATPase subunits 1 (PSMD1) and 3 (PSMD3) were recently identified as prognostic biomarkers and potential therapeutic targets in chronic myeloid leukemia (CML) and multiple solid tumors. In the present study, we analyzed the expression of 19S proteasome subunits in acute myeloid leu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara, Joshua J., Bencomo-Alvarez, Alfonso E., Gonzalez, Mayra A., Olivas, Idaly M., Young, James E., Lopez, Jose L., Velazquez, Vanessa V., Glovier, Steven, Keivan, Mehrshad, Rubio, Andres J., Dang, Sara K., Solecki, Jonathan P., Allen, Jesse C., Tapia, Desiree N., Tychhon, Boranai, Astudillo, Gonzalo E., Jordan, Connor, Chandrashekar, Darshan S., Eiring, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740165/
https://www.ncbi.nlm.nih.gov/pubmed/36498916
http://dx.doi.org/10.3390/ijms232314586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740165/
https://www.ncbi.nlm.nih.gov/pubmed/36498916
http://dx.doi.org/10.3390/ijms232314586

Ejemplares similares